Mission Wealth Management LP Raises Stock Holdings in Agilent Technologies, Inc. $A

Mission Wealth Management LP boosted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 17.6% in the second quarter, HoldingsChannel reports. The institutional investor owned 28,282 shares of the medical research company’s stock after acquiring an additional 4,233 shares during the quarter. Mission Wealth Management LP’s holdings in Agilent Technologies were worth $3,757,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. State Street Corp increased its position in shares of Agilent Technologies by 1.9% in the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after acquiring an additional 241,029 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Agilent Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after purchasing an additional 25,139 shares during the period. Morgan Stanley grew its stake in shares of Agilent Technologies by 15.9% in the fourth quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after purchasing an additional 692,202 shares during the last quarter. Norges Bank purchased a new position in Agilent Technologies during the 4th quarter valued at about $549,158,000. Finally, Cantillon Capital Management LLC increased its holdings in Agilent Technologies by 0.8% during the 4th quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company’s stock valued at $423,945,000 after purchasing an additional 23,493 shares during the period.

Agilent Technologies Price Performance

Shares of A stock opened at $148.28 on Thursday. The stock has a market cap of $41.88 billion, a price-to-earnings ratio of 29.78, a PEG ratio of 2.65 and a beta of 1.25. The business’s fifty day moving average is $134.90 and its 200 day moving average is $125.30. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter last year, the firm posted $1.31 earnings per share. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts expect that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th were given a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.

Wall Street Analyst Weigh In

A has been the subject of several research analyst reports. HSBC dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Barclays upped their target price on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Jefferies Financial Group began coverage on Agilent Technologies in a research note on Thursday, July 9th. They issued a “hold” rating and a $135.00 price target for the company. Robert W. Baird boosted their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Finally, Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their price objective for the stock from $150.00 to $145.00 in a report on Thursday, May 28th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.